Opinion: One number keeps me from taking part in cystic fibrosis trials. That’s wrong
AGNES BALASA
Including a broader patient population in cystic fibrosis trials is important for understanding the effects of a new drug on those with lower FEV1 scores.
No hay comentarios:
Publicar un comentario